Qilu Hospital of Shandong University
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.qiluhospital.com
Effect of EPAP Device on Emphysema and Lung Bullae
- Conditions
- Bullous Disease LungEmphysema
- Interventions
- Device: use the face mask without Expiratory Positive Airway Pressure(EPAP).Device: use the face mask with Expiratory Positive Airway Pressure(EPAP).
- First Posted Date
- 2021-02-05
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 200
- Registration Number
- NCT04742114
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
- Conditions
- Acute Coronary SyndromeHelicobacter Pylori Infection
- Interventions
- First Posted Date
- 2021-01-28
- Last Posted Date
- 2021-08-03
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 2600
- Registration Number
- NCT04728516
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
🇨🇳Qilu Hospital of Shandong University (Qingdao), Qingdao, Shandong, China
🇨🇳The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Prospective Study of FMT for Acute Intestinal GVHD After Allo-HSCT
- Conditions
- Acute Graft Versus Host Disease in Intestine
- Interventions
- Biological: Fecal Microbiota TransplantationDrug: drug
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2021-08-31
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 20
- Registration Number
- NCT04711967
- Locations
- 🇨🇳
Shandong university qilu hospital, Jinan, Shandong, China
🇨🇳Peking university people's hospital, Beijing, Beijing, China
A Prospective, Single-centre，Single-blinded Study of PROUD for Prostate Carcinoma Diagnosis
- Conditions
- Prostate Carcinoma
- Interventions
- Diagnostic Test: The level of CNV
- First Posted Date
- 2021-01-07
- Last Posted Date
- 2021-01-07
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 500
- Registration Number
- NCT04699344
- Locations
- 🇨🇳
Urology Department of Qiluhospital, Jinan, Shandong, China
Derivation of An In-Hospital Cardiac Arrest Prediction Model for Patients in Intensive Care Unit
- Conditions
- In-Hospital Cardiac Arrest
- Interventions
- Other: no intervention
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 2000
- Registration Number
- NCT04670458
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Systemic Propranolol for the Treatment of Paediatric Patients With Infantile Hemangiomas
- First Posted Date
- 2020-12-03
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 128
- Registration Number
- NCT04651049
Neoadjuvant Immunotherapy to ESCC
- Conditions
- Esophagus SCC
- Interventions
- First Posted Date
- 2020-11-12
- Last Posted Date
- 2022-04-26
- Lead Sponsor
- Qilu Hospital of Shandong University
- Registration Number
- NCT04625543
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Bevacizumab in Patients With Severe Covid-19
- Conditions
- COVID-19 Pneumonia
- Interventions
- First Posted Date
- 2020-03-12
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 588
- Registration Number
- NCT04305106
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia
- First Posted Date
- 2020-02-19
- Last Posted Date
- 2020-09-14
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 27
- Registration Number
- NCT04275414
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
🇮🇹Moriggia-Pelascini Gravedona Hospital, Gravedona, Italy
🇨🇳Renmin Hospital of Wuhan University, Wuhan, Hubei, China
2019-nCoV Outbreak and Cardiovascular Diseases
- Conditions
- Cardiovascular Death; Major Adverse Cardiovascular Events
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 12000
- Registration Number
- NCT04255940
- Locations
- 🇨🇳
First Hospital Affiliated with Shandong First Medical University, Jinan, Shandong, China
🇨🇳The Second Hospital of Shandong University, Jinan, Shandong, China
🇨🇳Affiliated Hospital of Binzhou Medical Universty, Binzhou, Shandong, China